Inhibition of Pneumocystis carinii dihydropteroate synthetase by sulfa drugs
- PMID: 2203302
- PMCID: PMC171761
- DOI: 10.1128/AAC.34.6.1075
Inhibition of Pneumocystis carinii dihydropteroate synthetase by sulfa drugs
Abstract
A new reversed-phase high-pressure liquid chromatography assay procedure for dihydropteroate synthetase (DHPS) that involves the elution of the enzyme incubation solution with a series of three solvents of decreasing polarity (ammonium phosphate buffer, 10% methanol, and 50% methanol) was designed. By this procedure DHPS was detected in Escherichia coli and Pneumocystis carinii with specific activities of 450 and 14 U/mg, respectively. A comparison of the effects of five sulfa drugs on P. carinii DHPS activity revealed that dapsone is the most potent of these drugs.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
